Register entry
BWXT Medical Ltd.
- Registered sites
- 2
- Drug products
- 6
- Live patents
- 0
- Countries
- 1
- Base
- Canada
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites
Facilities
2| Site | Location | Operations | FEI |
|---|---|---|---|
| BWXT Medical Ltd. | OttawaCanada | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3001092088 |
| BWXT Medical Ltd. | VancouverCanada | Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging | 3004005970 |
Catalogue
Marketed products
6Showing 6 of 6.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Germanium Ge-68 Chloride | LIQUID | DRUG FOR FURTHER PROCESSING |
| Indium In 111 Oxyquinoline | Indium In-111 Oxyquinoline | LIQUID | ANDA |
| - | Indium In-111 Chloride | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Sodium iodide I-123 | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Sodium iodide I-123 | POWDER | DRUG FOR FURTHER PROCESSING |
| - | Strontium Sr-82 Chloride | LIQUID | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.